Fundamentals Data provided by Morningstar.Data provided by Morningstar.
52 Week Range
Avg. Volume (1 month)
as at 24 Feb 3:44pm
3 ASX healthcare shares rocketing 20% to 100% today
Why has the Advanced Health Intelligence share price rocketed 370% this week?
ASX tech share Advanced Human Imaging share price frozen after rocketing 96%
Here's a look at the laggards from ASX tech shares last quarter
Why has the Advanced Human Imaging (ASX:AHI) share price plummeted 57% in a month?
Up 27% this week, what's with the Advanced Human Imaging (ASX:AHI) share price?
The Advanced Human Imaging (ASX:AHI) share price is leaping 46%. Why?
What sent the Advanced Human Imaging (ASX:AHI) share price down 18% today?
Here's why the Advanced Human Imaging (ASX:AHI) share price is frozen
Advanced Human Imaging (ASX:AHI) share price sinks on US listing update
Why Advanced Human Imaging, ResMed, Western Areas, and Westpac are falling
What's with the Advanced Human Imaging (ASX:AHI) share price today?
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
|Date||Announcement||Price Sensitive?||Time||No. of Pages||File Size|
A software company which has developed a software application MyFiziq Technology and App for Smart Phones. The app converts photos of the human body into 3D image known as a Personal Avatar.
|04 Dec 2023||$0.10||$0.00||0.00%||188,337||$0.10||$0.11||$0.10|
|01 Dec 2023||$0.10||$-0.01||-9.09%||333,830||$0.12||$0.12||$0.10|
|29 Nov 2023||$0.11||$0.00||0.00%||140,694||$0.11||$0.11||$0.10|
|28 Nov 2023||$0.11||$0.02||21.05%||173,149||$0.10||$0.11||$0.10|
|27 Nov 2023||$0.10||$-0.01||-10.00%||228,545||$0.10||$0.11||$0.10|
|24 Nov 2023||$0.10||$0.00||0.00%||11,235||$0.11||$0.11||$0.10|
|23 Nov 2023||$0.10||$0.00||0.00%||4,306||$0.11||$0.11||$0.10|
|22 Nov 2023||$0.10||$0.00||0.00%||487,974||$0.11||$0.11||$0.10|
|21 Nov 2023||$0.11||$-0.01||-8.70%||153,531||$0.11||$0.11||$0.11|
|20 Nov 2023||$0.12||$0.02||20.00%||460,859||$0.11||$0.12||$0.10|
|17 Nov 2023||$0.10||$0.00||0.00%||64,143||$0.11||$0.11||$0.10|
|16 Nov 2023||$0.10||$0.00||0.00%||242,131||$0.11||$0.11||$0.10|
|15 Nov 2023||$0.11||$0.00||0.00%||137,296||$0.11||$0.11||$0.11|
|14 Nov 2023||$0.11||$0.00||0.00%||75,103||$0.11||$0.11||$0.10|
|13 Nov 2023||$0.11||$-0.01||-9.09%||118,506||$0.11||$0.11||$0.11|
|10 Nov 2023||$0.11||$-0.01||-8.33%||217,722||$0.12||$0.12||$0.11|
|09 Nov 2023||$0.12||$0.01||9.09%||117,487||$0.11||$0.12||$0.11|
|08 Nov 2023||$0.11||$0.00||0.00%||225,551||$0.11||$0.11||$0.11|
|07 Nov 2023||$0.11||$0.01||10.00%||403,771||$0.11||$0.12||$0.11|
|22 Mar 2023||Katherine Iscoe||Transfer||391,864||$31,349||
|19 Dec 2022||Katherine Iscoe||Transfer||17,000,000||$1,000,000||
|Mr Michael (Mike) Melby||Non-Executive Director||Oct 2017||
Mr Melby was Vice President at New Evolution Ventures, where he invested in and operated health clubs worldwide and served as an executive at UFC Gym. Prior to that, he was co-founder of two technology start-ups (both of which exited to publicly traded companies), a private equity investor with ClearLight Partners and an investment banker with FBR Capital Markets.
|Mr Nicholas (Nick) Prosser||Non-Executive DirectorInterim Chairman||Apr 2018||
Mr Prosser combines over 14 years of experience in the ICT sector and over 10 years as a founder, entrepreneur and private investor. He has also served on the board of directors of Vudoo Pty Ltd, a video technology and SaaS platform, since January 2017. Additionally, he has served as the executive director of CPDone Pty Ltd, a financial profession compliance company.
|Mr Koon Poh Low||Non-Executive Director||Jul 2020||
Mr Low has 24 years of combined experience in accounting, auditing and consultancy, with experience in corporate finance, auditing, and accounting in various industries such as construction, plantation, hotels, property, manufacturing and marketing.
|Ms Luisa Ingargiola||Non-Executive Director||Feb 2021||
Ms Ingargiola has almost 20 years of experience in public company finance, compliance, capital markets oversight and mergers and acquisitions. She currently serves as Chief Financial Officer of a NASDAQ biotech firm and Audit Chair of several Public companies including AgEagle (NYSE: UAVS), Vision Marine (NASDAQ:VMAR) and Progress Acquisition Corporation (NASDAQ:PGRWU), a new SPAC that recently completed their IPO. She has served multiple public companies in various Officer and Director roles. Ms Ingargiola has helped guide the uplist or IPO of several companies to NASDAQ or the NYSE.
|Mr Peter Joseph Goldstein||Non-Executive Director||Jun 2022||
Mr Goldstein has over 30 years of diverse and global entrepreneurial, client advisory and capital market experience. With a background in international business, he has worked across a range of markets and industries, holding positions including investment banker, chairman, chief executive officer, director and advisor to public, private, and emerging growth companies.
Mr Goldstein has achieved capital market objectives by drawing on his strengths in merges and acquisitions, strategic planning and transaction structuring, as well as his own entrepreneurial success. He has steered and completed IPOs, uplisting and reverse merger transactions, secured private placements and designed crowdfunding campaigns.
|Mr Scott Montgomery||Chief Executive OfficerExecutive Director||Dec 2022||
Mr Montgomery cofounded the Wellteq group of companies in October 2013 and has served as CEO, President, and Director since incorporation. Mr Montgomery's background is well positioned in the healthcare sector with over 20 years of industry experience around the world, both as a founder and director of public and private companies.
|Ms Jacqueline Yee||Non-Executive Director||Dec 2022||
Ms Jacqueline Yee joins AHI's Board of Directors as a non-executive independent Director. Ms Yee has an impressive background having spent over 30 years as
an institutional finance professional out of New York, London, Amsterdam, Australia and currently resides in Singapore. Throughout her career to date, Ms Yee has been involved in over $25 billion in transaction value with a notable volume of work in the healthcare sector, including restructuring of 27 national hospitals and the drafting of Healthcare Investment Valuation Policy in New Zealand.
|Mr Simon Francis Durack||Chief Financial OfficerCompany Secretary||Mar 2022||
|Simon Francis Durack||Chief Financial OfficerCompany Secretary||
|Hsbc Custody Nominees (Australia) Limited||62,910,406||28.90%|
|Katherine Elisabeth Iscoe||17,000,000||7.81%|
|Mad Scientist Pty Ltd||16,900,000||7.76%|
|Citicorp Nominees Pty Limited||9,240,593||4.24%|
|Mr Nicholas John Blair Prosser||7,015,036||3.22%|
|Fitlab Fund Management Llc||4,000,000||1.84%|
|Computershare Investor Service [Unexchanged Wellteq Sholders]||3,926,116||1.80%|
|Bnp Paribas Noms Pty Ltd Uobkh A/C R'Miers [Drp]||2,047,381||0.94%|
|Ifm Pty Limited||2,014,959||0.93%|
|J15I Pte Ltd (W E F 16/06/2017)||2,000,000||0.92%|
|Pheakes Pty Ltd||2,000,000||0.92%|
|Celtic Capital Pty Ltd||1,781,371||0.82%|
|Seaza Pty Ltd [Smtm Share A/C]||1,610,000||0.74%|
|Mr Adrian Addario||1,600,000||0.73%|
|Pheakes Pty Ltd [Senate A/C]||1,581,177||0.73%|
|Ms Soheila Taebi||1,516,214||0.70%|
|Bnp Paribas Noms Pty Ltd [Drp]||1,508,935||0.69%|
|Mr John Zaccaria The [Zaccaria Share A/C]||1,500,000||0.69%|
|Td Waterhouse Canada Inc||1,460,490||0.67%|